Modality Solutions Achieves ISO 9001:2015 Recertification, Expands Certification Scope to Greenwood Laboratory
Modality Solutions has successfully achieved recertification to the ISO 9001:2015 standard, reaffirming its commitment...
read Details
Amicus Therapeutics announces EC approval for Pombiliti™
Amicus Therapeutics announces EC approval for Pombiliti™
Congratulations to Amicus Therapeutics for their European Commission approval for Pombiliti™ in patients with Late-Onset Pompe Disease. We applaud Amicus and are proud to have contributed to their cold chain over the last seven years with full validation master planning and transport simulation.
Stay on top of the industry trends
You may also like
Modality Solutions, Suttons Creek, CLINTREX, and ToxStrategies—announce their unification under a new brand: BlueRidge Life Sciences
Today, four leading life science companies—Suttons Creek, Modality Solutions, CLINTREX, and ToxStrategies—announce their unification...
read Details
Modality Solutions’ New Greenwood Lab Slashes Lead Times and Expands Testing
Modality Solutions is proud to announce the launch of our new Greenwood Lab—a state-of-the-art...
read Details